My view is that, like a lot of small businesses trying to grow overseas, COVID has stopped them in their tracks. Result - they will need further funding to get them to the point they hoped to be at 6 months ago. However, there are enough large strategic investors on the register, and maybe outside it, to make it happen. Digital health for Asthma/other respiratory issues is a great place to be long term - this will not be lost on companies and investors in the sector when they look at Adherium.
Ann: Final Director's Interest Notice, page-19
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.861M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 288622 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 293516 | 1 |
View Market Depth
| Last trade - 16.12pm 11/09/2024 (20 minute delay) ? |
| ADR (ASX) Chart |
Day chart unavailable